Kuniaki Ogasawara Selected Research

Xenon-133

7/2002	Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study.
2/2002	Very early and standard Tc-99m ethyl cysteinate dimer SPECT imaging in a patient with reperfusion hyperemia after acute cerebral embolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kuniaki Ogasawara Research Topics

Disease

25	Neoplasms (Cancer) 07/2022 - 05/2002
22	Stroke (Strokes) 01/2022 - 02/2002
20	Carotid Stenosis (Carotid Artery Stenosis) 01/2021 - 09/2003
18	Pathologic Constriction (Stenosis) 06/2021 - 09/2003
15	Aneurysm (Aneurysms) 07/2021 - 11/2006
13	Glioblastoma (Glioblastoma Multiforme) 11/2019 - 05/2002
11	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022 - 11/2004
11	Cognitive Dysfunction 01/2021 - 06/2003
10	Brain Ischemia (Cerebral Ischemia) 12/2021 - 10/2004
8	Intracranial Aneurysm (Cerebral Aneurysm) 01/2022 - 11/2006
7	Ischemic Stroke 12/2021 - 06/2005
6	Glioma (Gliomas) 07/2022 - 05/2002
6	Transient Ischemic Attack 12/2021 - 03/2006
5	Moyamoya Disease (Moya-Moya Disease) 01/2022 - 11/2018
5	Hemorrhage 01/2022 - 01/2008
4	Cerebral Hemorrhage 08/2022 - 10/2004
4	Atrial Fibrillation 01/2022 - 01/2013
4	Hematoma 01/2022 - 08/2005
4	Ischemia 08/2018 - 07/2006
4	Poisoning 11/2016 - 08/2010
4	Astrocytoma (Pilocytic Astrocytoma) 02/2013 - 01/2003
4	Demyelinating Diseases (Demyelinating Disease) 08/2012 - 09/2009
4	Neurologic Manifestations (Neurological Manifestations) 09/2011 - 10/2004
3	Infections 01/2022 - 04/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2011
3	Albuminuria 01/2020 - 01/2012
3	Myocardial Infarction 01/2019 - 09/2012
3	Hypertension (High Blood Pressure) 01/2018 - 08/2011
3	Necrosis 12/2016 - 01/2007
3	Intracranial Vasospasm 02/2014 - 01/2008
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2003 - 02/2002
2	Thrombosis (Thrombus) 05/2022 - 03/2007
2	Rupture 01/2022 - 01/2022
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 12/2007
2	Headache (Headaches) 01/2022 - 01/2011
2	COVID-19 01/2022 - 01/2022
2	Embolism (Embolus) 01/2021 - 01/2018
2	Chronic Renal Insufficiency 12/2016 - 01/2011
2	Brain Neoplasms (Brain Tumor) 12/2016 - 01/2007
2	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 12/2015 - 08/2012
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 04/2011 - 05/2009
2	Syringomyelia (Morvan's Disease) 01/2011 - 08/2010

Drug/Important Bio-Agent (IBA)

13	Acetazolamide (Diamox)FDA LinkGeneric 12/2021 - 07/2002
11	Oxygen (Dioxygen)IBA 01/2019 - 05/2002
4	Temozolomide (Temodar)FDA LinkGeneric 07/2022 - 03/2009
4	GABA-A Receptors (GABA(A) Receptor)IBA 01/2022 - 02/2009
4	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2021 - 11/2004
4	CreatinineIBA 01/2020 - 12/2013
4	AlbuminsIBA 01/2020 - 12/2013
4	Bevacizumab (Avastin)FDA Link 11/2019 - 11/2016
4	Indicators and Reagents (Reagents)IBA 10/2019 - 01/2005
4	Protons (Proton)IBA 08/2018 - 06/2005
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 12/2011
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2007
4	Carbon MonoxideIBA 11/2016 - 08/2010
4	EdaravoneIBA 12/2015 - 11/2004
4	Free Radical ScavengersIBA 12/2015 - 10/2005
3	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2022 - 11/2018
3	Antihypertensive Agents (Antihypertensives)IBA 12/2021 - 09/2014
3	SodiumIBA 10/2019 - 01/2008
3	Cilostazol (Pletal)FDA LinkGeneric 05/2019 - 05/2013
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2019 - 05/2013
3	iomazenilIBA 12/2018 - 01/2010
3	LipidsIBA 01/2018 - 11/2012
3	ethyl cysteinate dimerIBA 01/2018 - 02/2002
3	C-Reactive ProteinIBA 01/2018 - 06/2008
3	sphingosine phosphorylcholineIBA 02/2014 - 01/2008
3	oxidized low density lipoproteinIBA 10/2013 - 06/2007
3	Myelin Basic ProteinIBA 08/2012 - 08/2010
3	Glutamic Acid (Glutamate)FDA Link 09/2009 - 02/2002
2	AnticoagulantsIBA 01/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
2	COVID-19 VaccinesIBA 01/2022 - 01/2022
2	Amino Acids FDA Link 11/2019 - 02/2002
2	Clopidogrel (Plavix)FDA Link 05/2019 - 11/2018
2	neodymium pyrocatechin disulfonate (NPD)IBA 04/2015 - 12/2013
2	HDL CholesterolIBA 08/2014 - 09/2012
2	rho-Associated KinasesIBA 02/2014 - 01/2008
2	Eicosapentaenoic AcidIBA 02/2014 - 01/2008
2	AdrenomedullinIBA 09/2013 - 01/2008
2	NimustineIBA 02/2013 - 01/2003
2	Cytidine Triphosphate (CTP)IBA 05/2012 - 07/2011
2	AlloysIBA 06/2010 - 11/2006

Therapy/Procedure

32	Carotid Endarterectomy 06/2021 - 10/2004
17	Therapeutics 07/2022 - 01/2003
10	Endarterectomy (Thromboendarterectomy) 01/2021 - 03/2007
9	Craniotomy 01/2022 - 02/2004
8	Surgical Instruments (Clip) 06/2010 - 11/2006
5	Radiotherapy 01/2022 - 01/2003
4	Operative Surgical Procedures 02/2018 - 04/2005
3	Catheters 05/2022 - 01/2008
3	Stents 01/2022 - 05/2009
3	Cerebral Revascularization 11/2020 - 06/2005
2	Adjuvant Chemotherapy 07/2022 - 02/2013
2	Drug Therapy (Chemotherapy) 01/2022 - 02/2020
2	Operative Time 09/2021 - 11/2020
2	Thrombectomy 01/2021 - 10/2019
2	Intravenous Administration 11/2019 - 03/2006
2	Laminectomy 08/2016 - 01/2011
2	Decompression 01/2011 - 08/2010